🔎 Trials Near Me

홈 › 전이성 암 › 오리건

오리건의 전이성 암 임상 시험

전이성 암 관련 연구 29개가 오리건 내 여러 지역에서 참여자를 모집하고 있습니다.

오리건의 도시

공식 연구 텍스트(영어)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Providence Newberg Medical Center, Newberg
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario
  • Providence Willamette Falls Medical Center, Oregon City
  • 외 3개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Oregon Health and Science University, Portland
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Willamette Valley Cancer Institute, Eugene
  • Oregon Health and Science University, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07562152

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Good Samaritan Regional Medical Center, Corvallis
  • Oncology Associates of Oregon, Eugene
  • Oregon Health and Science University, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • USO - Oncology Associates of Oregon, P. C., Eugene
  • Providence Portland Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Oncology Associates of Oregon, Eugene
  • Asante Rogue Regional Medical Center, Medford
  • Providence Portland Medical Center, Portland
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • Oregon Health and Science University, Portland
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06943755

A Study of MGC026 in Participants With Advanced Solid Tumors

  • Providence Cancer Institute, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

  • Oregon Health & Science University Knight Cancer Institute, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06127407

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Oregon Health & Science University, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT04657068

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

  • Oregon Health & Science University, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT05875168

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • OHSU Center for Health & Healing 1, Portland
  • Oregon Health and Science University, Portland
  • OSHU Center for Health and Healing 2, Portland
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06989437

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Oregon Health and Science University, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT05382559

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

  • OHSU Knight Cancer Institute, Portland
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07405086

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  • OHSU Research Integrity, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Northwest Cancer Specialists, P.C., Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07227415

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Northwest Cancer Specialists, P.C, Happy Valley
  • Northwest Cancer Specialists, P.C., Portland
  • Northwest Cancer Specialists, P.C, Tigard
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07222566

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Oncology Associates of Oregon, P.C., Albany
  • Kaiser Permanente Sunnyside Medical Center, Clackamas
  • Oncology Associates of Oregon, P.C., Corvallis
  • 외 4개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07222800

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT07218380

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Oregon Health and Science University, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Oregon Health & Science University (OHSU), Portland
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 6, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

  • Providence Portland Medical Center, Portland
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 24. 업데이트됨 · NCT07543055

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Eugene
  • Research Site, Portland
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #121, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06974110

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

  • OHSU Knight Cancer Institute, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06320405

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • VA Portland Health Care System, Portland
피험자 모집 중2상
18세 이상 · 남성 · 2026. 6. 15. 업데이트됨 · NCT05422911

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

  • Providence Cancer Institute, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 6. 업데이트됨 · NCT06171750

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Portland
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.